MedTrace Logo

Phenylephrine Versus Ephedrine in Pre-eclampsia

NCT02025426 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2020-10-14

Study results available
· View outcomes & findings →

Summary

Phenylephrine administration is associated with reductions in CO and SctO2 compared with ephedrine when used for blood pressure management in women with pre-eclampsia undergoing cesarean delivery under spinal anesthesia.

Conditions

  • Pre-eclampsia

Interventions

DRUG

Phenylephrine

DRUG

Ephedrine

Sponsors & Collaborators

Principal Investigators

  • Ashraf S Habib, MD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2016-07-08
Completion
2016-07-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02025426 on ClinicalTrials.gov